POLYPOIDAL CHOROIDAL VASCULOPATHY MANIFESTATION IN EXTRA-AXIAL CAVERNOUS TUMOR: A RARE FINDINGS IN CHRONIC PAPILLEDEMA
Main Article Content
Abstract
Introduction: Age-related macular degeneration (AMD) is a leading cause of blindness worldwide. Polypoidal choroidal vasculopathy (PCV), a subtype of neovascular AMD, is characterized by an abnormal branching network of vessels with aneurysmal dilations (polyps). Choroidal neovascularization can also result from chronic disc edema. This case presents a rare occurrence of PCV in a patient with an extra-axial cavernous tumor and explores the best management approach.
Case Report: A 43-year-old man presented with an 8-month history of blurry vision in his right eye, double vision on left gaze, and left eye protrusion, accompanied by headaches and occasional nausea. Visual acuity was 2/60 in the right eye and 5/10 in the left improving with pinhole become 5/6.5. RAPD was found in left eye. Funduscopy revealed peripapillary atrophy in both eyes, with exudates in the right macula. OCT showed dome-shaped polyps in both eyes, larger in the right. MRI revealed a left sphenoid meningioma compressing the orbital cavity. The patient was diagnosed with both eyes PCV and compressive optic neuropathy, left eye multiple cranial nerve palsy and dyslipidemia. Intravitreal anti-VEGF injection was planned.
Discussion PCV is a subtype of AMD characterized by recurrent serosanguineous detachments. Chronic papilledema, possibly due to intracranial tumors, may lead to visual loss from retinal nerve fiber damage or neovascularization. Chronic posterior globe flattening and choroidal vessel abnormalities likely contributed to PCV development.
Conclusion: PCV may result from chronic papilledema due to intracranial tumors. Anti-VEGF therapy offers a viable treatment option, balancing polyp regression and visual acuity stabilization.
Keywords
Polypoidal Choroidal Vasculopathy, Choroidal neovascularization, Papilledema, Meningioma
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
2. Wong CW, Yanagi Y, Lee WK, et al. Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians. Prog Retin Eye Res. 2016;53:107e139.
3. Tagoe NN, Sharma RA, Biousse V. Optic disc edema due to peripapillary choroidal neovascularization. Taiwan J Ophthalmol. 2021 Jan 20;11(1):93-96. doi: 10.4103/tjo.tjo_77_20. PMID: 33767962; PMCID: PMC7971433.
4. Monteiro ML, Hoyt WF, Imes RK, Narahara M. [Unilateral pa- pilledema in pseudotumor cerebri]. Arq Neuropsiquiatr. 1985; 43(2):154-9.
5. Coppeto JR, Monteiro ML. Juxtapapillary subretinal hemorrhages in pseudotumor cerebri. J Clin Neuroophthalmol. 1985;5(1):45-53.
6. Kim SJ, Fawzi A., Kovach JL, Patel S, Recchia FM., Sobrin L, Sun JK, Wykoff C. 2023. Age-Related Macular Degeneration and Other Causes of Choroidal Neovascularization in Basic and Clinical Science Course Section 12: Retina and Vitreous. American Academy of Ophthalmology, San Francisco, California. p85-93
7. Cheung CMG, Lai TYY, Ruamviboonsuk P, Chen SJ, Chen Y, Freund KB, Gomi F, Koh AH, Lee WK, Wong TY. Polypoidal Choroidal Vasculopathy: Definition, Pathogenesis, Diagnosis, and Management. Ophthalmology. 2018 May;125(5):708-724. doi: 10.1016/j.ophtha.2017.11.019. Epub 2018 Jan 10. PMID: 29331556.
8. Cackett P, Yeo I, Cheung CM, et al. Relationship of smoking and cardiovascular risk factors with polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese persons. Ophthalmology. 2011;118(5):846e852.
9. Woo SJ, Ahn J, Morrison MA, et al. Analysis of genetic and environmental risk factors and their interactions in Korean patients with age-related macular degeneration. PLoS One. 2015;10(7):e0132771.
10. Kikuchi M, Nakamura M, Ishikawa K, et al. Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration. Ophthalmology. 2007;114(9): 1722e1727.
11. Laude A, Cackett PD, Vithana EN, et al. Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease? Prog Retin Eye Res. 2010;29(1):19e29.
12. Sakurada Y, Nakamura Y, Yoneyama S, et al. Aqueous humor cytokine levels in patients with polypoidal choroidal vasculopathy and neovascular age-related macular degener- ation. Ophthalmic Res. 2015;53(1):2e7.
13. Dansingani KK, Balaratnasingam C, Naysan J, Freund KB. En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography. Retina. 2016;36(3):499e516.
14. Ozawa S, Ishikawa K, Ito Y, et al. Differences in macular morphology between polypoidal choroidal vasculopathy and exudative age-related macular degeneration detected by op- tical coherence tomography. Retina. 2009;29(6):793e802.
15. Chen JJ, Bhatti MT. Papilledema. Int Ophthalmol Clin. 2019;59(3):3-22.
16. Monteiro ML, Afonso CL. Macular thickness measurements with frequency domain-OCT for quantification of axonal loss in chronic papilledema from pseudotumor cerebri syndrome. Eye (Lond). 2014;28(4):390-8.
17. Villarruel JM, Li XQ, Bach-Holm D, Hamann S. Anterior lamina cribrosa surface position in idiopathic intracranial hypertension and glaucoma. Eur J Ophthalmol. 2017;27(1):55-61.
18. Matos AMF, Cunha LP, Suzuki ACF, Mello LGM, Preti RC, Zacharias LC, Monteiro MLR. Unilateral papilledema and peripapillary polypoidal choroidal vasculopathy as the presenting manifestations of intracranial hypertension. Arq Bras Oftalmol. 2021 Nov-Dec;84(6):598-601. doi: 10.5935/0004-2749.20210098. PMID: 34431881.